Hardware Podcasts

115 - Bottle of Lies, Generic Drugs Quality, Ranbaxy, Audits, and Inspiring Quality Pros with NYT Best-Selling Author, Katherine Eban

Let's Combinate · 20 Dec 2023 · 33m

What this episode covers

Katherine Eban, author of the New York Times bestseller 'Bottle of Lies', discusses her decade-long investigation into quality failures in the generic drug industry, focusing on the fraudulent practices of Indian manufacturer Ranbaxy. She details how Ranbaxy manipulated and fabricated data to secure regulatory approvals, creating a 'dual-track' system where lower-quality drugs were sent to less regulated markets while better-tested versions went to the US and Europe. Eban highlights the role of whistleblower Dinesh Takur and FDA inspector Peter Baker in uncovering these systemic issues, while also critiquing the FDA's reliance on pre-announced inspections and the ethical culture of pharmaceutical companies.

Most relevant to

large enterprises

Topics

Mentioned

Companies
Ranbaxy, FDA, Pfizer, Purdue Pharma, People's Pharmacy, WHO, Self Magazine, Fortune Magazine, PDA
Products
Bottle of Lies, Oxycontin
Also
Joe Graden, Dinesh Takur, Peter Baker, Lester Crawford

Related episodes from other shows

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 45m

    Quality Myths and Lessons Learned

    Kevin Becker, author of 'Quality Myths and Lessons Learned' and Director of Quality at a med device component manufacturer, discusses common pitfalls in medical device quality engineering. He explains how misaligned incentives can lead to unethical behavior, such as falsifying data or hiding defects during FDA audits, and emphasizes the need for principle-based decision-making to overcome peer pressure and 'normalization of deviance.' Becker argues that management support is the most critical component of a Quality Management System (QMS) and shares lessons on statistical misconceptions, effective flowcharting, and the importance of integrity in engineering.

    Quality & yieldLeadership, teams & culture
    8 chapters

  • Global Medical Device Podcast · 30m

    What are the Top Compliance Issues Plaguing Medical Device Manufacturers?

    Tom Rynkiewicz, VP of RA/QA at Raland Compliance Partners, joins host John Spear to discuss the top compliance issues plaguing medical device manufacturers, specifically CAPA, complaints, and design controls. Rynkiewicz argues that these recurring FDA observations stem from flawed internal audit practices that audit isolated quality system components rather than the entire system holistically. He highlights how human behavior and corporate KPIs, such as tracking CAPA turnaround times instead of effectiveness, prevent companies from achieving a true quality culture with zero complaints. The conversation emphasizes the need for system-level auditing and transparency to prepare for potential FDA shifts toward stricter Good Manufacturing Practices (GMP) inspections.

    Quality & yieldCertification & compliance
    7 chapters

  • Global Medical Device Podcast · 52m

    Fraud in the Healthcare Industry & the Role of Whistleblowers

    Jonathan Tycko, a founding partner at Tycko & Zavareei LLP, explains the False Claims Act and its application to the medical device industry, highlighting how fraud on the FDA, anti-kickback violations, and improper billing can lead to massive penalties. He details the whistleblower process, noting that the government intervenes in about 20% of cases but wins most of them, and discusses the financial rewards for relators. Tycko advises companies to foster internal compliance cultures to prevent employees from going to the government, emphasizing that individual executives can face criminal charges for intentional fraud.

    Policy, trade & tariffsLeadership, teams & culture
    9 chapters

  • Global Medical Device Podcast · 36m

    FDA is Expanding its Case for Quality Program... Should Your Company Participate?

    Mike Drues of Vascular Sciences and John Spear of Greenlight Guru discuss the FDA's expansion of the Case for Quality initiative, a pilot program involving the CMMI Institute and MDIC that shifts focus from mere compliance to true product quality. They analyze the benefits for participating companies, such as exemption from routine inspections and expedited PMA supplement reviews, while debating whether the program's inclusion of non-compliant companies constitutes helpful guidance or inappropriate micromanagement. The conversation highlights the tension between regulatory hurdles and the need for continuous improvement in medical device manufacturing.

    Certification & complianceQuality & yield
    7 chapters

  • Global Medical Device Podcast · 38m

    Meet a Guru: Erica Loring

    Erica Loring, a medical device guru at Greenlight Guru, discusses her background in pharmaceuticals and IVDs, emphasizing the critical distinction between Quality Assurance and Regulatory Affairs. She explains how the 'throw it over the wall' mentality creates documentation gaps and costly remediation, advocating for cross-functional collaboration from concept to market. Loring highlights the importance of investing in people, allowing adequate time for development, and rigorously auditing suppliers to ensure successful product launches.

    Quality & yieldCertification & compliance
    7 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.